Pfaffenhofen facility
Daiichi Sankyo Expands Cancer Research and Manufacturing Capacity in Germany
Daiichi Sankyo, antibody-drug conjugates (ADCs), cancer research, manufacturing capacity, Germany, Pfaffenhofen facility, innovation center
Actionable Insights Powered by AI
Daiichi Sankyo, antibody-drug conjugates (ADCs), cancer research, manufacturing capacity, Germany, Pfaffenhofen facility, innovation center